ADCs are currently at the forefront of cancer treatment, but persistent drug development challenges call for a new approach.

Experts debate whether European manufacturers are preferring domestic operations as the continent competes with Asia and the ...

Callio Therapeutics has raised $187m in Series A financing round for achieving clinical proof-of-concept for HER2-targeted ...

Widespread integration of machine learning (ML) into supply chain management by major pharma suppliers is just a few years ...

AstraZeneca's Imfinzi (durvalumab) plus chemotherapy, has gained CHMP recommendation for approval in the EU to treat NSCLC.

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

Nuvation Bio has secured $250m in non-dilutive financing from Sagard, aimed at funding the commercialisation of taletrectinib ...

Cell and gene therapies have undergone notable milestones in the last 12 months, with solid tumors and diabetes treatments.

At MWC Barcelona 2025, Li Peng delivered a keynote on how carriers can make the most of AI to fully unleash the value of ...

Teesside University's National Horizons Centre (NHC) is committed to turning groundbreaking ideas into practical solutions.

Download our expert guide for real world data pharmaceutical solutions. Discover what to explore leading RWE and RWD providers to enhance patient outcomes and drive innovation in the pharmaceutical ...

BridgeBio Oncology has entered into a merger agreement with Helix Acquisition Corp II to form a combined entity.